Document Detail


Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases.
MedLine Citation:
PMID:  16115126     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A number of growth factors are involved in clonal haematopoietic expansion and their clinical significance in patients with chronic myeloproliferative diseases requires further evaluation. Using enzyme-linked immunosorbent assays, we analysed serum levels of interleukin (IL)-1a, IL-1b, IL-2, IL-6, the soluble IL-2 receptor alpha (sIL-2Ra), and thrombopoietin (TPO), in 25 individuals with myelofibrosis with myeloid metaplasia (MMM), 40 with essential thrombocythaemia (ET), eight with polycythaemia vera (PV), 10 patients with chronic myeloid leukaemia (CML) and 27 normal controls. These were correlated with clinicopathological characteristics including overall survival, and histopathological bone marrow features, including angiogenesis. The serum derived from patients with MMM, ET, PV and CML contained significantly higher IL-2 and sIL-2Ra than healthy subjects, while IL-6 levels were higher only in MMM and CML than controls. IL-2, sIL-2Ra and IL-6 levels were raised during the transformation phase of CML, during progression of MMM to AML, and ET and PV to myelofibrosis (P < 0.001). There was a positive correlation between IL-2, sIL-2Ra, IL-6 and angiogenesis in bone marrow samples. Cytokines may be useful markers for predicting clinical evolution, reflecting increased angiogenesis. This requires further evaluation to guide diagnostic and therapeutic options.
Authors:
Katerina E Panteli; Eleftheria C Hatzimichael; Paraskevi K Bouranta; Afroditi Katsaraki; Konstantinos Seferiadis; Justin Stebbing; Konstantinos L Bourantas
Related Documents :
10908406 - Systematic review of randomized trials of the effect of exercise on bone mass in pre- a...
6748826 - Otosclerosis and endolymphatic hydrops.
1392266 - A screening and counseling program for prevention of osteoporosis.
18359366 - Influence of topical application of basic fibroblast growth factor upon inner ear.
8581086 - Exercise in the treatment of childhood obesity.
12640006 - Reflex sympathetic activation during static exercise is severely impaired in patients w...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of haematology     Volume:  130     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-08-23     Completed Date:  2005-10-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  709-15     Citation Subset:  IM    
Affiliation:
Haematology Clinic, University Hospital of Ioannina, Ioannina, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Antigens, CD34 / analysis
Biological Markers / analysis,  blood
Bone Marrow / pathology
Bone Marrow Examination
Case-Control Studies
Cytokines / blood*
Enzyme-Linked Immunosorbent Assay / methods
Female
Fibrosis
Humans
Interleukin-1 / blood
Interleukin-2 / blood
Interleukin-6 / blood
Male
Middle Aged
Myeloproliferative Disorders / blood*,  mortality,  pathology
Neovascularization, Pathologic
Receptors, Interleukin-2 / blood
Statistics, Nonparametric
Survival Rate
Thrombopoietin / blood
Chemical
Reg. No./Substance:
0/Antigens, CD34; 0/Biological Markers; 0/Cytokines; 0/Interleukin-1; 0/Interleukin-2; 0/Interleukin-6; 0/Receptors, Interleukin-2; 9014-42-0/Thrombopoietin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.
Next Document:  Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promy...